Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration

Cell Biology and Toxicology

Volumn 27, Issue 1, 2011, Pages 13-40

  Molyneux, Gemma ^a   Andrews, Michael ^b   Sones, William ^a,c   York, Malcolm ^b   Barnett, Anne ^a   Quirk, Edel ^a   Yeung, Wing ^a   Turton, John ^a,d  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Busulphan; Cisplatin; Cyclophosphamide; Doxorubicin; Haemotoxicity; Mouse

Indexed keywords

BUSULFAN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HEMOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD TOXICITY; BONE MARROW DISEASE; CELL VOLUME; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG SCREENING; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOCYTE COUNT;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD CELLS; BONE MARROW CELLS; BUSULFAN; CELL COUNT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HEMATOCRIT; HEMOGLOBINS; MICE; MICE, INBRED BALB C;

MUS;

EID: 79151471281     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-010-9167-1     Document Type: Article

References (177)

1. RGM Aitchison JCW Marsh JM Hows NH Russell EC Gordon-Smith 1989 Pregnancy-associated aplastic anaemia: a report of five cases and a review of current management Brit J Haematol 73 541 545 1:STN:280:DyaK3c7it1Knug%3D%3D 10.1111/j.1365-2141.1989.tb00294.x
2. P Alexander DI Connell 1960 Shortening of the life span of mice by irradiation with X-rays and treatment with radiomimetic chemicals Radiat Res 12 38 48 1:CAS:528:DyaF3cXpt1Sqtg%3D%3D 13792596 10.2307/3570821
3. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Orkin SH, editors. Hematology of infancy and childhood. Philadelphia: Saunders; 1998. p. 111-222.
4. BP Alter NU Potter FP Li 1978 Classification and aetiology of the aplastic anaemias Clin Haematol 7 431 465 1:STN:280:DyaE1M%2FmsVeisQ%3D%3D 363321
5. A Anagnostou A Zander J Barone W Fried 1976 Mechanism of the increased splenic erythropoiesis in mice treated with estradiol benzoate J Lab Clin Med 88 700 706 1:CAS:528:DyaE2sXht1SjsA%3D%3D 978038
6. D Anderson JB Bishop RC Garner P Ostrosky-Wegman PB Selby 1995 Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks Mutat Res 330 115 181 1:CAS:528:DyaK2MXnt1Ohs7k%3D 7623863
7. Andrews CM. Studies on the haemotoxicity of busulphan and chloramphenicol in the B6C3F1 mouse. PhD thesis, University of London; 2000.
8. CM Andrews NW Spurling JA Turton 1993 Characterisation of busulphan-induced myelotoxicity in B6C3F1 mice using flow cytometry Comp Haematol Int 3 102 115 1:CAS:528:DyaK2cXitlGmurc%3D 10.1007/BF00368113
9. CM Andrews LM Dash TC Williams J Craig Gray JA Turton 1997 Long-term effects of busulphan on lymphocyte subpopulations in female B6C3F1 mice Comp Haematol Int 7 230 237 1:CAS:528:DyaK1cXnsFCrsA%3D%3D 10.1007/BF02658695
10. CM Andrews TC Williams JA Turton 1998 Long-term haematological alterations in female B6C3F1 mice treated with busulphan Comp Haematol Int 8 125 138 1:CAS:528:DyaK1MXmsFaq 10.1007/BF02642503
11. E Anton 1993 Differential sensitivity of DBA/2 and C57BL/6 mice to cyclophosphamide J Appl Toxicol 13 423 427 1:CAS:528:DyaK2cXitlWqsA%3D%3D 8288846 10.1002/jat.2550130609
12. FR Appelbaum A Fefer 1981 The pathogenesis of aplastic anemia Semin Hematol 18 241 257 1:STN:280:DyaL38%2FjvFKlsg%3D%3D 6117130
13. M Asano TT Odell TP McDonald AC Upton 1963 Radiomimetic agents and X-rays in mice and AET protectiveness Arch Path 75 250 263 1:CAS:528: DyaF3sXktFSnsLg%3D 13965090
14. N Asna H Lewy IE Ashkenazi V Deutsch H Peretz M Inbar IG Ron 2005 Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity Life Sci 76 1825 1834 1:CAS:528:DC%2BD2MXhtFGrt7o%3D 15698860 10.1016/j.lfs.2004.09.028
15. OA Badary S Abdel-Maksoud WA Ahmed GH Owieda 2005 Naringenin attenuates cisplatin nephrotoxicity in rats Life Sci 76 2125 2135 1:CAS:528: DC%2BD2MXhtlGhsbs%3D 15826879 10.1016/j.lfs.2004.11.005
16. SF Badylak JF Van Vleet EH Herman VJ Ferrans CE Meyers 1985 Poikilocytosis in dogs with chronic doxorubicin toxicosis Am J Vet Res 46 505 508 1:STN:280:DyaL2M7pslWjtw%3D%3D 3922263
17. P Benedetti Panici S Greggi G Scambia G Baiocchi M Lomonaco G Conti S Mancuso 1993 Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up Int J Gynecol Cancer 3 44 43 11578321 10.1046/j.1525-1438.1993.03010044.x
18. Benestad H. Drug mechanisms in marrow aplasia. In: Geary CG, editor. Aplastic anaemia. London: Balliere-Tindall; 1979. p. 26-42.
19. RS Benjamin PH Wiernik NR Bachur 1974 Adriamycin chemotherapy; efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule Cancer 33 19 27 1:STN:280:DyaE2c%2FotVejtw%3D%3D 4810094 10.1002/1097- 0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M
20. J Berger 1981 Erythrokinetic study: morphology of the bone marrow and blood following experimental induction of marrow hypoplasia by cyclophosphamide in laboratory rats Folia Haematol Leipzig 108 97 106 1:CAS:528: DyaL3MXitVamtb8%3D
21. J Berger 1982 A quantitative study on the recovery of rat marrow erythropoietic cells after experimental suppression of erythropoiesis by repeated doses of cyclophosphamide Folia Haematol Leipzig 109 255 263 1:CAS:528:DyaL38XktFKmtr4%3D
22. A Berrebi L Shvidel M Shtalrid A Klepfish 2000 Short course of busulphan in essential thrombocythaemia: remodelling of an old strategy Br J Haematol 109 249 250 1:STN:280:DC%2BD3czgvVSqug%3D%3D 10848807
23. C Bertazzoli T Chieli G Ferni G Ricevuti E Solcia 1972 Chronic toxicity of adriamycin: a new antineoplastic antibiotic Toxicol Appl Pharmacol 21 287 301 1:CAS:528:DyaE38XhsV2is7o%3D 5027964 10.1016/0041-008X(72)90149-4
24. ML Bloom AG Wolk KL Simon-Stoos JS Bard J Chen NS Young 2004 A mouse model of lymphocyte infusion-induced bone marrow failure Exp Hematol 32 1163 1172 1:CAS:528:DC%2BD2cXhtVKrtbjN 15588941 10.1016/j.exphem.2004.08.006
25. RH Blum SK Carter 1974 A new anticancer drug with significant clinical activity Ann Intern Med 80 249 2459 1:CAS:528:DyaE2cXht1Oqtrw%3D 4590654
26. BNF. British National Formulary. London: British Medical Association; September 2007.
27. DR Boggs SS Boggs 1980 The effect of graded, single doses of busulphan on murine erythropoiesis Proc Soc Exp Biol Med 163 181 186 1:CAS:528: DyaL3cXhvFWgs7c%3D 7360747
28. G Bonadonna S Monfardini M De Lena F Fossati-Bellani 1969 Clinical evaluation of adriamycin, a new antitumour antibiotic Br Med J 3 503 506 1:STN:280:DyaF1M3lvFyhug%3D%3D 5257148 10.1136/bmj.3.5669.503
29. G Bonadonna G Beretta G Tancini C Brambilla E Bajetta GM De Palo M De Lena F Fossati Bellani M Gasparini P Valagussa U Veronesi 1975 Adriamycin (NSC-123127) studies at the Instituto Nazionale Tumori, Milan Cancer Chemother Rep 6 231 245
30. RL Boyd JC Caro KG Halka A Erslev 1986 Granulopoiesis in long-term culture by marrow from mice with busulphan-induced chronic latent aplasia Int J Cell Cloning 4 357 367 1:STN:280:DyaL2s%2FjsFWitg%3D%3D 3772175 10.1002/stem.5530040507
31. R Boyne JR Arthur 1990 Anaemia and changes in erythrocyte morphology associated with copper and selenium deficiencies and dietary restriction in rats Res Vet Sci 49 151 156 1:CAS:528:DyaK3MXhsVWqsb0%3D 2236909
32. R Bright S Eisendrath L Damon 2001 A case of factitious aplastic anemia Int J Psychiatry Med 31 433 441 1:STN:280:DC%2BD383htlyhsA%3D%3D 11949741 10.2190/TUJB-B2M7-6UPV-XPLV
33. RA Brodsky LL Sensenbrenner BD Smith D Dorr PJ Seaman SM Lee JE Karp I Brodsky RJ Jones 2001 Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia Ann Intern Med 135 477 483 1:CAS:528:DC%2BD3MXns1Kit7c%3D 11578150
34. LR Bucci ML Meistrich 1987 Effects of busulphan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations Mutat Res 176 259 268 1:CAS:528:DyaL2sXhtFehtb8%3D 3807936
35. WA Burns W McFarland MJ Matthews 1970 Busulphan-induced pulmonary disease. Report of a case and review of the literature Am Rev Respir Dis 101 408 412 1:STN:280:DyaE3c7gvFyktQ%3D%3D 5263678
36. J Chen 2005 Animal models for acquired bone marrow failure syndromes Clin Med Res 3 102 108 16012128 10.3121/cmr.3.2.102
37. J Chen K Lipovsky FM Ellison RT Calado NS Young 2004 Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure Blood 104 1671 1678 1:CAS:528: DC%2BD2cXns1OktL0%3D 15166031 10.1182/blood-2004-03-1115
38. KM Chiu WH Knospe 1989a Immunologically mediated aplastic anemia in mice: effects of varying the source and composition of donor cells Exp Hematol 15 269 275
39. KM Chiu WH Knospe 1989b Inhibitor of granulocyte-macrophage colony formation in plasma of mice rendered aplastic by allogenic lymph node cells Exp Hematol 17 335 339 1:STN:280:DyaL1M3htFWntA%3D%3D
40. E Cohen Y Ilan S Gillis EJ Dann EA Rachmilewitz 1993 Recurrent bone marrow hypoplasia associated with pregnancy Acta Haematol 89 32 34 1:STN:280:DyaK3s3ktlSktg%3D%3D 8480483 10.1159/000204479
41. RL Comis 1994 Cisplatin: the future Semin Oncol 21 Suppl 12 109 113 1:STN:280:DyaK2M%2FosVWksg%3D%3D 7992062
42. CF Craddock JF Apperley EG Wright LE Healy CA Bennett M Evans PG Grimsley MY Gordon 1992 Circulating stem cells in mice treated with cyclophosphamide Blood 80 264 269 1:CAS:528:DyaK38XkvVeisrY%3D 1611093
43. O De Weerdt NWCJ van de Donk G Veth AC Bloem A Hagenbeek HM Lokhorst 2001 Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma Neth J Med 59 50 56 11476912 10.1016/S0300-2977(01)00140-1
44. GJ Den Ottolander J Te Velde W Veenhof K Kleiverda HL Haak PJ Spaander 1982 Busulphan aplasia in rabbits: a model for human aplastic anemia Br J Haematol 51 265 276
45. WD DeWys A Goldin N Mantel 1970 Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity Cancer Res 30 1692 1697 1:CAS:528:DyaE3cXkvVKhsbY%3D 5457936
46. LK Diamond M Shahidi 1967 Treatment of aplastic anaemia in children Semin Hematol 4 278 288 1:STN:280:DyaF1c%2FpsVGjuw%3D%3D 4294607
47. Dollery C. Therapeutic drugs. Edinburgh: Churchill Livingstone; 1999.
48. PP Dukes E Goldwasser 1961 Inhibition of erythropoiesis by estrogens Endocrinology 69 21 29 1:CAS:528:DyaF3MXhtlagtbc%3D 13724883 10.1210/endo-69-1-21
49. R Duncan JK Coatsworth S Burtles 1998 Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1) Hum Exp Toxicol 17 93 104 1:CAS:528:DyaK1cXhsF2rurc%3D 9506260 10.1191/096032798678908378
50. CDR Dunn LA Elson 1970 The comparative effect of busulphan ("myleran") and aminochlorambucil on haemopoietic colony forming units in the rat Cell Tissue Kinet 3 131 141 1:CAS:528:DyaE3cXktFaku78%3D 4942743
51. P Ehrlich 1888 Uber einem Fall von Anämie mit Bemerkungen über regenerative Veränderungen des Knochenmarks [On a case of anaemia with remarks concerning regenerative changes in bone marrow] Charité-Annalen 13 300 309
52. LA Elson 1955 A comparison of the effects of radiation and radiomimetic chemicals on the blood Br J Haematol 1 104 116 1:STN:280:DyaG2M7gt1altg%3D%3D 13240000 10.1111/j.1365-2141.1955.tb05492.x
53. LA Elson DAG Galton M Till 1958 The action of chlorambucil (CB. 1348) and busulphan (myleran) on the haemopoietic organs of the rat Br J Haematol 4 355 374 1:STN:280:DyaG1M%2FisF2hsA%3D%3D 13596520 10.1111/j.1365-2141.1958.tb06038.x
54. G Falkson B Klein H Falkson 1985 Hematological toxicity: experience with anthracyclines and anthracenes Exp Hematol 13 Suppl 16 64 71 1:CAS:528:DyaL2MXlsFentrg%3D 3857185
55. FAO/WHO. Expert Committee on Food Additives. Chloramphenicol. In: Toxicological evaluation of certain veterinary drug residues in food. WHO Food Additives Series 23. Geneva: World health Organisation; 1988:1-71.
56. ML Feingold LG Koss 1969 Effects of long-term administration of busulphan Arch Intern Med 124 66 71 1:STN:280:DyaF1M3islyqsA%3D%3D 5255526 10.1001/archinte.124.1.66
57. J Fitchen MJ Cline 1980 The effect of granulopoietic stress in mice with "latent" bone marrow failure Exp Hematol 8 788 794 1:STN:280:DyaL3M7jvVGrsQ%3D%3D 7202582
58. AF Fleming 1968 Hypoplastic anaemia in pregnancy J Obstet Gynaec Brit Cwlth 75 138 141 1:STN:280:DyaF1c7mtFOitQ%3D%3D
59. AF Fleming 1999 Pregnancy and aplastic anaemia Br J Haematol 105 315 1:STN:280:DyaK1M3ptFOhtg%3D%3D 10366247 10.1111/j.1365-2141.1999.1368c.x
60. CV Ford R Stein MP Kelly LM Adelson 1984 Single case study; factitial aplastic anemia J Nerv Ment Dis 172 369 372 1:STN:280:DyaL28%2FmtFKltw%3D%3D 6544810 10.1097/00005053-198406000-00010
61. LH Frasier S Kanekal JP Kehrer 1991 Cyclophosphamide toxicity; characterising and avoiding the problem Drugs 42 781 795 10.2165/00003495- 199142050-00005
62. Freedman MH. Inherited forms of bone marrow failure. In: Hoffman R, Benz EJ, editors. Hematology: basic principles and practice. New York: Churchill Livingstone; 2000. p. 260-97.
63. W Fried C Johnson 1968 The effect of cyclophosphamide on hematopoietic stem cells Radiat Res 36 521 527 1:CAS:528:DyaF1MXislGiug%3D%3D 17387883 10.2307/3572585
64. J Gaedeke LM Fels C Bokemeyer U Mengs H Stolte H Lentzen 1996 Cisplatin nephrotoxicity and protection by silibinin Nephrol Dial Transplant 11 55 62 1:CAS:528:DyaK28XksFeiu70%3D 8649653
65. RJ Gale AA Morley 1980 The mononuclear phagocyte system in experimental chronic marrow failure Exp Hematol 8 16 24 1:STN:280:DyaL3M%2FgsVajsQ%3D%3D 7409034
66. DA Gastineau HC Hoagland 1992 Hematologic effects of chemotherapy Semin Oncol 19 543 550 1:STN:280:DyaK3s%2FjtV2iug%3D%3D 1411652
67. FM Gibson CM Andrews P Diamanti S Rizzo G Macharia EC Gordon-Smith T Williams J Turton 2003 A new model of busulphan-induced chronic bone marrow aplasia in the female BALB/c mouse Int J Exp Pathol 84 31 47 12694485 10.1046/j.1365-2613.2003.00239.x
68. GL Gilmore DK DePasquale RK Shadduck 1999 Protective effects of BB-10010 treatment on chemotherapy-induced neutropenia in mice Exp Hematol 27 195 202 1:CAS:528:DyaK1MXjt1Gitb0%3D 10029156 10.1016/S0301-472X(98)00052-6
69. EC Gordon-Smith S Issaragrissil 1992 Epidemiology of aplastic anaemia Bailliere's Clin Haematol 5 475 491 1:STN:280:DyaK38znvFemsA%3D%3D
70. Gordon-Smith EC, Lewis MS. Aplastic anaemia and other types of bone marrow failure. In: Hoffbrand AV, Lewis SM, Tuddenham EGD, editors. Postgraduate haematology. 4th ed. Oxford: Butterworth Heinemann; 1999. p. 68-90.
71. JA Gottlieb B Drewinko 1975 Review of the current clinical status of platinum coordination complexes in cancer chemotherapy Cancer Chemother Rep 59 621 628 1:STN:280:DyaE28%2FptVahtA%3D%3D 1106840
72. M Griesshammer M Bangerter T Sauer R Wennauer L Bergmann H Heimpel 1999 Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count J Int Med 245 295 300 1:STN:280: DyaK1M3it1ejtA%3D%3D 10.1046/j.1365-2796.1999.00452.x
73. HL Haak 1980 Experimental drug-induced aplastic anaemia Clin Haematol 9 621 639 1:STN:280:DyaL3M%2FovV2jsg%3D%3D 7004689
74. AG Hall MJ Tilby 1992 Mechanisms of actions of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies Blood Rev 6 163 173 1:STN:280:DyaK3s%2FksVOguw%3D%3D 1422285 10.1016/0268-960X(92) 90028-O
75. W Harrouk A Codrington R Vinson B Robaire BF Hales 2000 Paternal exposure to cyclophosphamide induces DNA damage and alters the expression of DNA repair genes in the rat preimplantation embryo Mutat Res 461 229 241 1:CAS:528:DC%2BD3cXosV2ju7c%3D 11056294
76. JE Hart 1985 Endocrine factors in haematological changes seen in dogs and ferrets given oestrogens Med Hypotheses 16 159 163 1:CAS:528:DyaL2MXhs1SlsrY%3D 3921810 10.1016/0306-9877(85)90070-2
77. JE Hart 1990 Endocrine pathology of oestrogens: species differences Pharmacol Ther 47 203 218 1:CAS:528:DyaK3cXlvVCktbk%3D 2203070 10.1016/0163-7258(90)90087-I
78. Heimpel H, Heit W. Drug-induced aplastic anaemia: clinical aspects. In: Gordon-Smith EC, editor. Clinics in haematology; haematological effects of drug therapy. Vol. 9, No. 3. London: Saunders; 1980. p. 641-62.
79. Heimpel H. Epidemiology and etiology of aplastic anaemia. In: Schrezenmeier H, Bacigulupo, editors. Aplastic anaemia: pathophysiology and treatment. Cambridge: Cambridge University Press; 2000. p. 97-116.
80. DJ Higby HJ Wallace JF Holland 1973 cis-Diamminedichloroplatinum (NSC-119875): a phase I study Cancer Chemother Rep 57 459 463 1:STN:280:DyaE2c%2FltlSmuw%3D%3D 4586953
81. DE Holt CM Andrews JP Payne TC Williams JA Turton 1998 The myelotoxicity of chloramphenicol: in vitro and in vivo studies: II: in vivo myelotoxicity in the B6C3F1 mouse Hum Exp Toxicol 17 8 17 1:CAS:528:DyaK1cXhtVaiu7g%3D 9491332 10.1191/096032798678907793
82. Home Office. Code of practice for the housing and care of animals used in scientific procedures. London: Her Majesty's Stationary Office; 1989.
83. H Host R Nissen-Meyer 1960 A preliminary clinical study of cyclophosphamide Cancer Chemother Rep 9 47 50 1:STN:280:DyaF3c%2FjsFKltQ%3D%3D 13716100
84. IARC. 1,4-Butanediol dimethanesulphonate (myleran) (group1). In: IARC Monographs on the evaluation of carcinogenic risks to humans (suppl. 7). Lyon: IARC; 1987. p. 137-39.
85. NM Ideriha I Vugman RP Falcao 1984 Ectopic bone marrow development in experimental busulphan-induced hypoplastic anaemia in mice Blut 48 277 284 1:STN:280:DyaL2c3gsVSqsA%3D%3D 6722358
86. Jandl H. Blood: textbook of hematology. Boston: Little Brown; 1996.
87. W Jelkmann C Bauer 1980 Beta 2-adrenergic stimulation of erythropoiesis in busulphan treated mice Exp Hematol 8 742 748 1:CAS:528:DyaL3cXlsVejsb4%3D 7202579
88. SA Johnson DS Richardson 1998 Anthracyclines in haematology: pharmacokinetics and clinical studies Blood Rev 12 52 71 1:STN:280: DyaK1c3lvFCrtA%3D%3D 9597198 10.1016/S0268-960X(98)90030-3
89. EM Kang MS Hsieh M Metzger A Krouse RE Donahue M Sadelain JF Tisdale 2006 Busulphan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model Exp Hematol 34 132 139 1:CAS:528:DC%2BD28XhtFWht7g%3D 16459181 10.1016/j.exphem.2005.10.010
90. DA Karnofsky 1967 Late effects of immunosuppressive anticancer drugs Fed Proc 26 925 933 1:CAS:528:DyaF2sXktV2qsrY%3D 5337286
91. T Kato Y Ohta Y Suzumura K Khoda H Kimoto Y Kawazoe 1988 Antitumor activity and neutrophil-selective hematopoietic toxicity of busulphan analogs in mice Jpn J Cancer Res (Gann) 79 1048 1053 1:CAS:528:DyaL1MXjtlCisQ%3D%3D
92. SR Kempf S Ivankovic 1986 Carcinogenic effect of cisplatin (cis-diammine-dichloroplatinum(II), CDDP) in BD XI rats J Cancer Res Clin Oncol 111 133 136 1:CAS:528:DyaL28XktFOqtLY%3D 3084495 10.1007/BF00400751
93. I Klimtova T Simunek Y Mazurova R Hrdina V Gersl 2000 Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits Hum Exp Toxicol 21 649 657 10.1191/0960327102ht311oa
94. WH Knospe D Steinberg B Speck 1983 Experimental immunologically mediated aplastic anemia (AA) in H-2k identical, Mls (M) locus different mice Exp Hematol 11 542 552 1:STN:280:DyaL2c%2FgsVyhsg%3D%3D 6617789
95. WH Knospe D Steinberg A Gratwohl B Speck 1984 Experimental immunologically mediated aplastic anemia (AA) in mice: cyclosporin A fails to protect against AA Int J Cell Cloning 2 263 271 1:CAS:528:DyaL2cXltVektbo%3D 6379064 10.1002/stem.5530020406
96. WH Knospe SG Husseini KM Chiu W Fried 1994 Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells Exp Hematol 22 573 581 1:STN:280:DyaK2c3otlGhtw%3D%3D 8013573
97. A Kreft C Nolde G Busche T Buhr H Kreipe A Georgii 2000 Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan Eur J Haematol 64 32 41 1:CAS:528:DC%2BD3cXhtl2htb0%3D 10680703 10.1034/j.1600-0609.2000.90031.x
98. HJ Lawrence J Simone RJA Aur 1975 Cyclophosphamide-induced hemorrhagic cystitis in children with leukaemia Cancer 36 1572 1576 1:STN:280: DyaE28%2FmsVSgsg%3D%3D 1059500 10.1002/1097-0142(197511)36:5<1572::AID- CNCR2820360506>3.0.CO;2-T
99. E Leake WG Smith HJ Woodliff 1963 Diffuse interstitial pulmonary fibrosis after busulphan therapy Lancet 2 432 434 1:STN:280:DyaF2c%2FgsVyntQ%3D%3D 14047274 10.1016/S0140-6736(63)92173-1
100. S Levin D Semler Z Ruben 1993 Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats Toxicol Pathol 21 1 14 1:CAS:528:DyaK3sXmsVyru7w%3D 8378702 10.1177/019262339302100101
101. AJ Lippman C Helson L Helson IH Krakoff 1973 Clinical trials of cis-diamminedichloroplatinum (NSC-119875) Cancer Chemother Rep 57 191 200 1:STN:280:DyaE2c%2FgsV2lsg%3D%3D 4126381
102. PJ Loehrer LH Einhorn 1984 Cisplatin Ann Intern Med 100 704 713 1:CAS:528:DyaL2cXktlalt78%3D 6370067
103. CC Lu ML Meistrich 1979 Cytotoxic effects of chemotherapeutic drugs on mouse testis cells Cancer Res 39 3575 3582 1:CAS:528:DyaE1MXlvVKlur4%3D 476683
104. K Maejima S Nagase 1991 Effect of starvation and refeeding on the circadian rhythms of haematological and clinicobiochemical values, and water intake of rats Exp Anim Tokyo 40 389 393 1:STN:280:DyaK38%2FgvVartQ%3D%3D
105. RJ Maral M Jouanne 1981 Toxicology of daunorubicin in animals and man Cancer Treat Rep 65 Suppl 4 9 18 1:CAS:528:DyaL38XlslChtr0%3D 6809317
106. J Marsh 1976 The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review Cancer Res 36 1853 1882 1:CAS:528:DyaE28XksVSnu70%3D 773531
107. JCW Marsh J Choudry N Parry-Jones SW Ellis KR Muir EC Gordon-Smith GT Tucker 1999 Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia Br J Haematol 104 266 270 1:STN:280:DyaK1M7lsl2qsQ%3D%3D 10050706 10.1046/j.1365-2141.1999.01190.x
108. T Matsuzawa M Sakazume 1994 Effects of fasting on haematology and clinical chemistry values in the rat and dog Comp Haematol Int 4 152 156 10.1007/BF00798356
109. PM McManus L Weiss 1984 Busulphan-induced chronic bone marrow failure: changes in cortical bone, marrow stromal cells, and adherent cell colonies Blood 64 1036 1041 1:STN:280:DyaL2M%2FitlOisw%3D%3D 6487805
110. MS Mitchell 1988 Combining chemotherapy with biological response modifiers in treatment of cancer J Natl Cancer Inst 80 1445 1450 1:STN:280:DyaL1M%2Fjslajtg%3D%3D 3054127 10.1093/jnci/80.18.1445
111. Molyneux G. Studies on the haemotoxicity of antineoplastic agents. PhD thesis, University of London; 2006.
112. G Molyneux S Rizzo FM Gibson S Sulsh CM Andrews AM Pilling T Nakshbandi EC Gordon-Smith JA Turton 2004 Haemotoxicity of chlorambucil in the Wistar Hanover rat with particular reference to bone marrow culture, marrow cell apoptosis and levels of FLT3 ligand Comp Clin Path 13 70 81 1:CAS:528: DC%2BD2cXovVKqtrk%3D 10.1007/s00580-004-0524-4
113. G Molyneux FM Gibson EC Gordon-Smith AM Pilling KC Liu S Rizzo S Sulsh JA Turton 2005 The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse Int J Exp Pathol 86 415 430 1:CAS:528:DC%2BD28Xps1elsw%3D%3D 16309546 10.1111/j.0959-9673.2005.00452.x
114. G Molyneux FM Gibson CM Chen HK Marway S McKeag CVJ Mifsud AM Pilling MJ Whayman JA Turton 2008 The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse Int J Exp Pathol 89 138 158 1:CAS:528: DC%2BD1cXltlKrtbg%3D 18336531 10.1111/j.1365-2613.2008.00575.x
115. A Morley 1980 Residual damage from cytotoxic drugs Aust N Z Med 10 569 571 1:STN:280:DyaL3M7jtlartg%3D%3D
116. A Morley F Stohlman 1970 Cyclophosphamide-induced cyclical neutropenia: an animal model of a human disease New Engl J Med 282 643 646 1:CAS:528:DyaE3cXktVantbw%3D 5417728 10.1056/NEJM197003192821202
117. A Morley J Blake 1974 An animal model of chronic hypoplastic marrow failure. Late marrow failure after busulphan Blood 44 49 56 1:STN:280: DyaE2c3lsFCksQ%3D%3D 4834516
118. A Morley J Blake 1974 Hemopoietic precursor cells in experimental hypoplastic marrow failure Aust J Exp Biol Med Sci 52 909 914 1:STN:280:DyaE2M7otlSltQ%3D%3D 4462526 10.1038/icb.1974.90
119. A Morley M Furness D Higgs 1974 Inhibition of growth of marrow cells by chloramphenicol Aust J Exp Biol Med Sci 52 847 850 1:STN:280: DyaE2M%2FptVSjsQ%3D%3D 4475582 10.1038/icb.1974.84
120. A Morley K Trainor J Blake 1975 A primary stem cell lesion in experimental chronic hypoplastic marrow failure Blood 45 681 688 1:STN:280:DyaE2M7ivVCquw%3D%3D 235339
121. A Morley J Remes K Trainor 1976 A controlled trial of androgen therapy in experimental chronic hypoplastic marrow failure Br J Haematol 32 533 536 1:CAS:528:DyaE28Xhs1Sjsrg%3D 1259935 10.1111/j.1365-2141.1976.tb00956.x
122. AA Morley KJ Trainor RS Seshadri 1978 Chronic hypoplastic marrow failure and residual injury Blood Cells 4 253 266 1:STN:280:DyaE1M7ksFOrsw%3D%3D 371698
123. A Morley K Trainor R Seshadri J Sorrell 1978 Is aplastic anaemia due to abnormality of D.N.A.? Lancet 2 9 12 1:CAS:528:DyaE1MXktFSq 78261 10.1016/S0140-6736(78)91321-1
124. MR Nowrousian CG Schmidt 1982 Effects of cisplatin on different haemopoietic progenitor cells in mice Br J Cancer 46 397 402 1:CAS:528:DyaL38XlslCltro%3D 6889884
125. DA O'Keefe DJ Schaeffer 1992 Hematologic toxicosis associated with doxorubicin administration in cats J Vet Intern Med 6 276 282 1432901 10.1111/j.1939-1676.1992.tb00352.x
126. A Oakhill ID Green GT Knowlson AH Cameron KJ Shah FGH Hill JR Mann 1981 Busulphan lung in childhood J Clin Pathol 34 495 500 1:STN:280: DyaL3M3ktVWktw%3D%3D 6941971 10.1136/jcp.34.5.495
127. GK Ogilvie RC Richardson CR Curtis SJ Withrow HA Reynolds AM Norris RA Henderson JS Klausner JD Fowler D McCaw 1989 Acute and short-term toxicoses associated with the administration of doxorubicin to dogs with malignant tumors J Am Vet Med Assoc 195 1584 1587 1:STN:280:DyaK3c%2Fptl2ktA%3D%3D 2599942
128. G Pearse A Pietersma J Cunliffe JR Foster J Turton N Derbyshire KJ Randall 2009 Time-course study of the immunotoxic effects of the anticancer drug chlorambucil in the rat Toxicol Pathol 37 887 901 1:CAS:528: DC%2BC3cXmvVKluw%3D%3D 19805614 10.1177/0192623309347907
129. FS Philips SS Sternberg AP Cronin PM Vidal 1961 Cyclophosphamide and urinary bladder toxicity Cancer Res 21 1577 1589 1:STN:280: DyaF38%2FoslOnsA%3D%3D 14486208
130. Pugsley CAJ, Forbes IJ, Morley AA. Disturbance of immunity in experimental chronic hypoplastic marrow failure. In: First International Symposium on Aplastic Anemia. Kyoto: University Park Press; 1978a. p. 123-31.
131. CAJ Pugsley IJ Forbes AA Morley 1978 Immunologic abnormalities in an animal model of chronic hypoplastic marrow failure induced by busulphan Blood 51 601 610 1:STN:280:DyaE1c7isVCruw%3D%3D 305267
132. FR Quinn GWA Milne 1986 Toxicities derived from anti-tumor screening data Fundam Appl Toxicol 6 270 277 1:CAS:528:DyaL28Xhs1WntL4%3D 3699317 10.1016/0272-0590(86)90240-X
133. Reynolds JEF. Martindale: the extra pharmacopoeia. 30th ed. London: Pharmaceutical Press; 1993.
134. DS Richardson SA Johnson 1997 Anthracyclines in haematology: preclinical studies, toxicity and delivery systems Blood Rev 11 201 223 1:STN:280: DyaK1c7kt1Cnuw%3D%3D 9481450 10.1016/S0268-960X(97)90020-5
135. AM Risitano 2005 New challenges to developing animal models for human immune-mediated marrow failure Clin Med Res 3 63 64 16012122 10.3121/cmr.3.2.63
136. SH Rosenoff F Bostic RC Young 1975 Recovery of normal hematopoietic tissue and tumor following chemotherapeutic injury from cyclophosphamide (CTX): comparative analysis of biochemical and clinical techniques Blood 45 465 475 1:CAS:528:DyaE2MXksFensbc%3D 1115838
137. GW Santos PJ Tutschka 1974 Marrow transplantation in the busulphan-treated rat: preclinical model of aplastic anemia J Natl Cancer Inst 53 1781 1785 1:STN:280:DyaE2M%2Fmt1Sntg%3D%3D 4612168
138. U Schaeppi IA Heyman RW Fleischman H Rosenkrantz V Ilievski R Phelan DA Cooney RD Davis 1973 cis-Dichlorodiammineplatinum (II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice Toxicol Appl Pharmacol 25 230 241 1:CAS:528:DyaE3sXkt1OntLY%3D 4197634 10.1016/S0041-008X(73)80009-2
139. AI Schafer 2004 Thrombocytosis New Engl J Med 350 1211 1219 1:CAS:528:DC%2BD2cXit12rtro%3D 15028825 10.1056/NEJMra035363
140. JE Schurig AP Florczyk WT Bradner 1973 The mouse as a model for predicting the myelosuppressive effects of anticancer drugs Cancer Chemother Pharmacol 16 243 246 10.1007/BF00293985
141. E Schwartz JA Tornaben GC Boxill 1973 The effects of food restriction on haematology, clinical chemistry and pathology in the albino rat Toxicol Appl Pharmacol 25 515 524 1:CAS:528:DyaE3sXkslOgtrY%3D 4741773 10.1016/0041-008X(73) 90020-3
142. A Sherrill J Gorman 1985 Bone marrow hypoplasia associated with estrus in ferrets Lab Anim Sci 35 280 286 1:STN:280:DyaL2M3ms1Snuw%3D%3D 4040589
143. Sparreboom A, Nooter K, Verweij J. Mechanism of action of cancer chemotherapeutic agents: antitumour antibiotics. In: Alison MR, editor. The cancer handbook. London: Nature Publishing Group; 2002. p. 1333-46.
144. SS Sternberg FS Philips J Scholler 1958 Pharmacological and pathological effects of alkylating agents Ann N Y Acad Sci 68 811 825 1:CAS:528: DyaG1cXpsVWnsA%3D%3D 13627734 10.1111/j.1749-6632.1958.tb42642.x
145. R Storb CD Buckner LA Dillingham ED Thomas 1970 Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion Cancer Res 30 2195 2203 1:CAS:528:DyaE3cXltVOqtL8%3D 4990004
146. SJ Susaneck 1983 Doxorubicin therapy in the dog J Am Vet Med Assoc 182 70 72 1:STN:280:DyaL3s7gvVGnuw%3D%3D 6822470
147. Sweetman SC. Martindale: the complete drug reference. 33rd ed. London: Pharmaceutical Press; 2002.
148. RW Talley RM O'Bryan JU Gutterman RW Brownlee KB McCredie 1973 Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875); phase I clinical study Cancer Chemother Rep 57 465 471 1:STN:280: DyaE2c%2FltlSlsg%3D%3D 4762440
149. HS Thompson GR Gale 1971 cis-Dichlorodiammineplatinum (II): hematopoietic effects in rats Toxicol Appl Pharmacol 19 602 609 1:CAS:528:DyaE3MXltl2itrs%3D 5132030 10.1016/0041-008X(71)90292-4
150. JF Tisdale DE Dunn N Geller M Plante O Nunez CE Dunbar AJ Barrett TJ Walsh SJ Rosenfeld NS Young 2000 High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial Lancet 356 1554 1559 1:CAS:528:DC%2BD3cXot12lsbo%3D 11075769 10.1016/S0140-6736(00)03126-3
151. KJ Trainor AA Morley 1976 Screening of cytotoxic drugs for residual bone marrow damage J Natl Cancer Inst 57 1237 1239 1:CAS:528:DyaE2sXotlOjtw%3D%3D 1003558
152. KJ Trainor RS Seshadri AA Morley 1979 Residual marrow injury following cytotoxic drugs Leuk Res 3 205 211 1:CAS:528:DyaL3cXhsFOhsA%3D%3D 533991 10.1016/0145-2126(79)90043-2
153. KJ Trainor AA Morley RS Seshadri 1980 A proliferative defect of marrow cells in experimental chronic hypoplastic marrow failure (aplastic anaemia) Exp Hematol 8 674 682 1:STN:280:DyaL3M7jvVGluw%3D%3D 6451444
154. JA Turton CM Andrews AC Havard TC Williams 2002 Studies on the haemotoxicity of chloramphenicol succinate in the Dunkin Hartley guinea pig Int J Exp Pathol 83 225 238 1:CAS:528:DC%2BD3sXis1GgsLY%3D 12641819 10.1046/j.1365-2613.2003.00232.x
155. JA Turton CM Andrews AC Havard S Robinson M York TC Williams FM Gibson 2002 Haemotoxicity of thiamphenicol in the BALB/c mouse and Wistar Hanover rat Food Chem Toxicol 40 1849 1861 1:CAS:528:DC%2BD38Xotlynsbo%3D 12419700 10.1016/S0278-6915(02)00178-3
156. JA Turton WR Sones CM Andrews AM Pilling TC Williams G Molyneux S Rizzo EC Gordon-Smith FM Gibson 2006 Further development of a mouse model of chronic bone marrow aplasia in the busulphan-treated mouse Int J Exp Pathol 87 49 63 1:CAS:528:DC%2BD28XislOktrw%3D 16436113 10.1111/j.0959-9673.2006.00455.x
157. FA Valeriote DC Collins WR Bruce 1968 Hematological recovery in the mouse following single doses of gamma radiation and cyclophosphamide Radiat Res 33 501 511 1:STN:280:DyaF1c7mtFWjtw%3D%3D 5640790 10.2307/3572407
158. JF Van Vleet LA Greenwood VJ Ferrans 1979 Pathologic features of adriamycin toxicosis in young pigs: nonskeletal lesions Am J Vet Res 40 1537 1552 525872
159. JF Van Vleet VJ Ferrans 1980 Clinical and pathologic features of chronic adriamycin toxicosis in rabbits Am J Vet Res 41 1462 1469 7447139
160. JF Van Vleet VJ Ferrans 1980 Clinical observations, cutaneous lesions, and hematologic alterations in chronic adriamycin intoxication in dogs with and without vitamin E and selenium supplementation Am J Vet Res 41 691 699 7406287
161. PC Vincent 1984 In vitro evidence of drug action in aplastic anaemia Blut 49 3 12 1:STN:280:DyaL2c3lvVShsg%3D%3D 6378281 10.1007/BF00320378
162. PC Vincent 1986 Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms Drugs 31 52 63 1:CAS:528:DyaL28XmtFersA%3D%3D 3940848 10.2165/00003495-198631010-00004
163. DD Von Hoff R Schilsky CM Reichert RL Reddick M Rozencweig RC Young FM Muggia 1979 Toxic effects of cis-dichlorodiammineplatinum(II) in man Cancer Treat Rep 63 1527 1531
164. S Wadler JF Fuks PH Wiernik 1986 Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds J Clin Pharmacol 26 491 509 1:STN:280:DyaL2s%2FgvFWntw%3D%3D 2944917
165. JM Ward KA Fauvie 1976 The nephrotoxic effects of cis-diammine- dichloroplatinum(II) (NSC-119875) in male F344 rats Toxicol Appl Pharmacol 38 535 547 1:CAS:528:DyaE2sXotlOlsA%3D%3D 1014012 10.1016/0041-008X(76)90185-X
166. PA Wood JM Hrushesky 1995 Cisplatin-associated anemia: an erythropoietin deficiency syndrome J Clin Invest 95 1650 1659 1:CAS:528:DyaK2MXkslykt7o%3D 7706473 10.1172/JCI117840
167. PK Working AD Dayan 1996 Pharmacological-toxicological expert report CAELYX (stealth liposomal doxorubicin HCl) Hum Exp Toxicol 15 752 785 10.1177/096032719601500906
168. AM Yeager C Shinn DM Pardoll 1991 Lymphoid reconstitution after transplantation of congenic /hematopoietic cells in busulphan-treated mice Blood 78 3312 3316 1:CAS:528:DyaK38XltFSrsA%3D%3D 1683798
169. N Young 1995 Aplastic anaemia Lancet 346 228 232 1:STN:280: DyaK2MzktF2htA%3D%3D 7616805 10.1016/S0140-6736(95)91273-8
170. Young NS, Alter BP. Aplastic anemia: acquired and inherited. Philadelphia: Saunders; 1994.
171. NS Young AJ Barrett 1995 The treatment of severe aplastic anemia Blood 85 3367 3377 1:CAS:528:DyaK2MXmtlOmtro%3D 7780125
172. N Young M Keisu 1996 Preface: drug-related blood dyscrasias workshop Eur J Haematol 57 Suppl. 5
173. NS Young JP Maciejewski 1997 The pathophysiology of acquired aplastic anemia New Engl J Med 336 1365 1372 1:CAS:528:DyaK2sXjtlOru7w%3D 9134878 10.1056/NEJM199702133360705
174. Young NS, Maciejewski JP. Aplastic anemia. In: Hoffman R, Benz EJ, editors. Hematology: basic principles and practice. New York: Churchill Livingstone; 2000. p. 297-331.
175. M Zak J Drobnik Z Rezny 1972 The effect of cis-platinum(II) diamminodichloride on bone marrow Cancer Res 32 595 599 1:CAS:528: DyaE38XktFCjtb0%3D 5061310
176. H Zaporowska W Wasilewski 1991 Significance of reduced food intake and water consumption with vanadium Comp Biochem Physiol 99C 349 352 1:CAS:528:DyaK3MXlslKqsLw%3D
177. H Zephir J de Seze A Duhamel M Debouverie P Hautecoeur C Lebrun I Malikova J Pelletier O Senechal P Vermersch 2004 Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients J Neurol Sci 218 73 77 1:CAS:528:DC%2BD2cXpsV2itw%3D%3D 14759636 10.1016/j.jns.2003.11.004